Business

Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding ...

articleWellgistics Health, Inc.June 25, 20253/company/wellgistics-health-inc-common-stock/news/wellgistics-health-nasdaqwgrx-accelerates-platform-growth-in-q2-with-116-manufacturer-partnerships-12400-new-products-and-275-pharmacies-added-to-its-expanding-tech-based-drug-ecosystem
Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem

About this update from Wellgistics Health, Inc.

[{"type":"text","content":"TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.","length":381,"tagName":"p"},{"type":"text","content":"This expansion reflects Wellgistics' accelerating momentum in creating a modern drug ecosystem-one that aims to connect manufacturers directly to pharmacies, providers, employers, and patients through a fully integrated, AI-powered infrastructure designed to streamline fulfillment, reduce costs, and bypass legacy bottlenecks.","length":331,"tagName":"p"},{"type":"text","content":""We're in hyper structural transformation mode," said Brian Norton, CEO of Wellgistics Health. "Pharma companies are signaling a shift. They want partners who can deliver speed, visibility, and direct access-not more layers of complexity. Every new manufacturer, every new product, and every new pharmacy is helping us rewire how prescriptions move in this country. We're laying the foundation for real-time, patient-first drug access at national scale."","length":482,"tagName":"p"},{"type":"text","content":"As Wellgistics continues to advance toward direct-to-patient care programs, the company intends to leverage its expanding distribution, fulfillment, and pharmacy network to support new models of care-aligning pharmaceutical manufacturers with a streamlined path to market while offering patients faster, more transparent prescription access.","length":341,"tagName":"p"},{"type":"text","content":"The Wellgistics platform spans the full prescription journey-from wholesale distribution and digital Rx routing to pharmacy dispensing and Hub Services including eligibility, prior authorization, adherence tracking, and patient engagement. With thousands of pharmacies on board and manufacturer demand accelerating, Wellgistics seeks to be a vital infrastructure partner for reshaping prescription drug delivery in the U.S.","length":423,"tagName":"p"},{"type":"text","content":"About Wellgistics Health","length":24,"tagName":"p"},{"type":"text","content":"Wellgistics Health (NASDAQ:WGRX) is a healthcare tech...

More updates from Wellgistics Health, Inc.

pharmaceutical manufacturerForward-Looking StatementsHub ServicesHealth